UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Ultragenyx Pharmaceutical
RARE
$2.55B
| $4.7M | ﹤0.01% |
60,098
-310
| -0.5% | -$20.5K |
|
1102
Vroom Inc
VRM
$48.2M
| $4.69M | ﹤0.01% |
+1,125
| New | +$4.36M |
|
1103
MGIC Investment
MTG
$6.25B
| $4.69M | ﹤0.01% |
572,073
-291,840
| -34% | -$2.18M |
|
1104
PENN Entertainment
PENN
$2.71B
| $4.67M | ﹤0.01% |
152,944
+8,099
| +6% | +$185K |
|
|
ETRN
1105
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $4.64M | ﹤0.01% |
558,420
+178,740
| +47% | +$1.41M |
|
1106
United Airlines
UAL
$42.1B
| $4.64M | ﹤0.01% |
134,057
-348,623
| -72% | -$10.5M |
|
1107
New Jersey Resources
NJR
$5.58B
| $4.64M | ﹤0.01% |
141,994
-155
| -0.1% | -$5.13K |
|
1108
American States Water
AWR
$3.46B
| $4.63M | ﹤0.01% |
58,927
-4,031
| -6% | -$321K |
|
1109
Beyond Meat
BYND
$277M
| $4.63M | ﹤0.01% |
34,573
+4,630
| +15% | +$548K |
|
1110
DigitalBridge
DBRG
$2.95B
| $4.63M | ﹤0.01% |
482,054
+2,273
| +0.5% | +$19.7K |
|
1111
Alarm.com
ALRM
$2.85B
| $4.61M | ﹤0.01% |
71,116
+5,178
| +8% | +$261K |
|
|
NEWR
1112
DELISTED
New Relic, Inc.
NEWR
| $4.58M | ﹤0.01% |
66,525
-8,383
| -11% | -$501K |
|
1113
Xenon Pharmaceuticals
XENE
$6.12B
| $4.57M | ﹤0.01% |
+364,757
| New | +$4.64M |
|
|
GBT
1114
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.56M | ﹤0.01% |
72,261
+282
| +0.4% | +$19.3K |
|
1115
Nexstar Media Group
NXST
$5.97B
| $4.56M | ﹤0.01% |
54,428
-26,669
| -33% | -$2.01M |
|
|
SVC
1116
Service Properties Trust
SVC
$1.07B
| $4.55M | ﹤0.01% |
128,463
-15,001
| -10% | -$522K |
|
1117
Arrowhead Research
ARWR
$12.4B
| $4.54M | ﹤0.01% |
105,174
+16,277
| +18% | +$574K |
|
|
SYNH
1118
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.54M | ﹤0.01% |
77,951
+8,005
| +11% | +$430K |
|
1119
HealthEquity
HQY
$8.75B
| $4.54M | ﹤0.01% |
77,349
+798
| +1% | +$44.1K |
|
1120
Dianthus Therapeutics
DNTH
$6.09B
| $4.51M | ﹤0.01% |
+37,500
| New | +$5.28M |
|
1121
Ares Management
ARES
$30.9B
| $4.5M | ﹤0.01% |
113,305
+24,702
| +28% | +$873K |
|
1122
Integra LifeSciences
IART
$1.34B
| $4.49M | ﹤0.01% |
95,588
-2,573
| -3% | -$126K |
|
|
SGI
1123
Somnigroup International
SGI
$13.7B
| $4.49M | ﹤0.01% |
249,440
-5,304
| -2% | -$76.1K |
|
1124
Portland General Electric
POR
$5.77B
| $4.48M | ﹤0.01% |
107,259
-4,063
| -4% | -$186K |
|
1125
MeiraGTx Holdings
MGTX
$1.21B
| $4.47M | ﹤0.01% |
357,414
+14,173
| +4% | +$198K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.